What Has Covid Ever Done for Us?
While COVID-19 devastated the world, what various developments in diagnostics and medical technology have occurred as a result of and in response to the pandemic? by Ivor Campbell The early 2020s...
COVID-19
The Importance of Routine Immunisation in a Post-COVID World
Immunisation is one of the most successful public health interventions but progress in the last two years has stalled or even reversed. COVID-19 and the threat of future pandemics have and will...
“Two-Faced” Miniproteins Protect Against Infection of Cells by SARS-CoV-2
Synthetic miniproteins that disable the entry of SARS-CoV-2 viruses into human cells have been developed, offering a potential alternative for enhanced protection from COVID-19. The constant waves of...
Researchers Report Fresh Insight Into SARS-CoV-2 Spike Protein Activation
The study suggests targeting spike proteolytic event at the S2’ site may be a potential antiviral option in curbing COVID-19 and future coronavirus infections. The number of COVID-19 infections has...
The First Anti-COVID-19 Stainless Steel Can Also Inactivate H1N1 and E.coli
This antiviral stainless steel can inactivate 99.75 per cent of SARS-CoV-2 virus within three hours and is expected to replace frequently touched stainless steel products in public areas to reduce...
Preparing for Crisis X — Not If but When
COVID-19 has highlighted the urgency for ASEAN leaders to collaborate and strategise viable and sustainable solutions for more resilient healthcare systems to withstand future challenges. It’s not...
Non-biological Estimate of Omicron Incidence
A mathematical method to describe the relative weight of two infections of different transmissibility is presented and applied to discuss the incidence of Omicron and Delta in two case studies (Italy...
New COVID-19 Saliva Amplified Antigen Rapid Test Is as Sensitive as PCR Test
A new saliva-based COVID-19 Antigen Rapid Test (ART) technology co-developed by the SingHealth Duke-NUS Academic Medical Centre and the National University of Singapore shows promise in early...
A Niclosamide-Based Oral Antiviral Drug – A Possible Cure for COVID-19 Variants
CP-COV03, a niclosamide-based oral antiviral drug, may be combined with dexamethasone to raise efficacy 2.1 times. Experimental results have been published for the first time showing that an...
Cross-Neutralising Antibodies Bring Hope for Broad Vaccine to Combat COVID-19 Variants and Future Coronavirus Outbreaks
Findings from a recent study can underpin a “dream” vaccine that tackles not only SARS-CoV-2 and its known variants of concerns, but also future variants and animal coronaviruses that may cause...
PIKA Recombinant COVID-19 Vaccine Receives Phase I Clinical Trial IND Clearance
YishengBio’s PIKA recombinant COVID-19 vaccine, a new generation of COVID-19 vaccines, receives IND approval from New Zealand Medicines and Medical Devices Safety Authority to conduct a Phase I...
Meeting Singapore’s Needs to Increase COVID-19 Testing
An interview with Mr. Abel Ang, Group Chief Executive of Advanced MedTech, on how AbAsia Biolabs can help Singapore meet the growing demand for COVID-19 test kits. As we begin to live with the new...